Related Experiment Video

Updated: Feb 27, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.9K

[CKD-MBD, cardiovascular involvement and prognosis]

Antonio Bellasi1,2, Michela Mangano1, Andrea Galassi1

  • 1U.O.C. di Nefrologia, Dialisi, Ospedale Sant'Anna-Como, ASST-Lariana, Como, Italy.

Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|July 7, 2017
PubMed

Insights

Chronic low-grade inflammation drives degenerative diseases like atherosclerosis. This study explores immune, metabolic, and inflammatory links, offering solutions for chronic kidney disease patients.

Area of Science:

  • Immunology
  • Metabolism
  • Pathophysiology

Background:

  • Chronic low-grade inflammation is a key factor in numerous chronic degenerative diseases.
  • Conditions such as atherosclerosis, inflammation, and oxidative stress are linked to this inflammatory state.
  • Understanding these interconnected issues is crucial for disease management.

Purpose of the Study:

  • To analyze the role of the immune system in chronic inflammation.
  • To investigate the involvement of metabolism in chronic inflammatory processes.
  • To provide an overview of molecular mediators of inflammation and their relevance to chronic kidney disease (CKD).

Main Methods:

  • Review and analysis of scientific literature.
  • Examination of the interplay between the immune system, metabolism, and inflammation.
  • Identification of molecular mediators involved in chronic inflammation.

Main Results:

  • Chronic low-grade inflammation is a unifying pathophysiological mechanism for various chronic diseases.
  • The immune system, metabolic processes, and specific molecular mediators are intricately linked in chronic inflammation.
  • These factors contribute to conditions including atherosclerosis and oxidative stress.

Conclusions:

  • The study provides a comprehensive overview of the interconnectedness of immune, metabolic, and inflammatory pathways in chronic diseases.
  • Proposed solutions aim to enhance survival and quality of life for patients with chronic kidney disease.
  • Targeting these pathways may offer therapeutic strategies for managing chronic inflammatory conditions.

Keywords:
CKD-MBD treatmentcalcium and phosphate balanceparathyroid hormonevitamin D

More Related Videos

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.9K
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

22.3K

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
768
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
508
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
667
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
843
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
534
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
565